key: cord-0763394-uhyepv9w
authors: Vosburg, R. Wesley; Pratt, Janey S.A.; Kindel, Tammy; Rogers, Ann M.; Kudav, Siddharth; Banerjee, Ambar; Hernandez, Edward; Athanasiadis, Dimitrios; Fischer, Laura E.; Hayes, Kellen; Shin, Thomas; Aminian, Ali; Kim, Julie J.
title: Bariatric Surgery is Safe for Patients After Recovery from COVID-19
date: 2021-07-31
journal: Surg Obes Relat Dis
DOI: 10.1016/j.soard.2021.07.018
sha: 94137661ea1bd57f443475b5e16418b32f6144b9
doc_id: 763394
cord_uid: uhyepv9w

BACKGROUND Studies of patients who have undergone surgery while infected with COVID-19 have shown increased risks for adverse outcomes in both pulmonary complications and mortality. It has become clear that the risk of complications from perioperative COVID-19 infection must be weighed against the risk from delayed surgical treatment. Studies have also shown that prior bariatric surgery conveys protection against mortality from COVID-19 and that obesity is the biggest risk factor for mortality from COVID-19 infection in adults under 45 years of age. Studies in patients who have fully recovered from COVID-19 and underwent elective surgery have not become widely available yet. OBJECTIVES This multi-institutional case series is presented to highlight patients who developed COVID-19, fully recovered, and subsequently underwent elective bariatric surgery with 30-day outcomes available. SETTING Nine bariatric surgery centers located across the United States. METHODS This multicenter case series is a retrospective chart review of patients who developed COVID-19, recovered, and subsequently underwent bariatric surgery. Fifty-three patients are included, and 30-day morbidity and mortality were analyzed. RESULTS Thirty-day complications included esophageal spasm, dehydration, and ileus. There were no cardiovascular, venous thromboembolism (VTE) or respiratory events reported. There were no 30- day mortalities. CONCLUSIONS Bariatric surgery has been safely performed in patients who made a full recovery from COVID-19 without increased complications due to cardiovascular, pulmonary, venous thromboembolism, or increased mortality rates.

In December, 2019, the coronavirus 2019 disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan, China [1] . COVID-19 disseminated rapidly throughout China and subsequently to the rest of the world resulting in a declaration of the disease as a pandemic by the World 5

Health Organization on March 11, 2020 [2] . This disease produced a wide clinical spectrum in infected patients ranging from asymptomatic carriers to critical illness and fatalities. After the first 70,000 cases a mortality rate was reported to be 2.3% [3] .

On March 13, 2020 the United States declared a national emergency due to COVID-19 [2] . Case numbers of COVID-19 surged and patient care facilities faced a 10 significant influx of patients with varying disease severity states and limited testing capacity. As a result of the rapidly changing situation public health measures were put into place by the Department of Public Health along with governmental leadership. The state of Massachusetts, for example, halted elective, non-emergent surgeries on March 15, 2020 in order to protect patients, health care professionals and to preserve critical 15 supplies of personal protective equipment [4] . At the time this paper was written the United States had recorded 29,573,712 cases and 537,417 deaths due to COVID-19

[5].

Initial reports from Aminian et.al, on a series of 3 patients who underwent uneventful elective surgeries and contracted COVID-19 in the peri-operative period 20 (incisional hernia repair, cholecystectomy, and cholecystectomy with concomitant hysterectomy) showed very concerning outcomes. Non-specific symptoms such as fever and cough combined with the lack of readily available and reliable testing along J o u r n a l P r e -p r o o f with no effective treatment strategies lead to a high morbidity and mortality rate in the patients infected after surgery (2 patients developed ARDS which progressed to death 25 and the third made a full recovery) [6] . Additionally, peri-operative COVID diagnoses have been found to cause up to a 50% risk of postoperative pulmonary complications with a high resulting mortality risk. This has resulted in recommendations to weigh the risk of surgery in COVID positive patients versus the risk of delayed surgical treatment [7] . 30

On June 8, 2020 elective surgical procedures were allowed to resume under phase II of Massachusetts reopening due to improving public health data related to COVID-19 [8] .

The patient series presented in this paper consists of patients who contracted COVID-19 during the pandemic. Prior to surgery they each made a recovery from the 35 disease and then underwent elective surgical weight loss procedures at 1 of 9 bariatric centers across the United States. The rationale for this study was to identify if 30-day morbidity or mortality rates were increased in patients who recovered from COVID-19 prior to bariatric surgery. We also sought to determine if consistencies existed in preoperative workup or postoperative care for these individuals with within this cohort. 40

School institutional review boards. IRB approval and data transfer agreements were contracted as required by each participating institution. Patient consent was waived due to the retrospective nature of the study. All patients with a COVID-19 diagnosis prior to 45 undergoing weight loss surgery at nine institutions in the United States were identified J o u r n a l P r e -p r o o f by electronic medical record review and included. All patients underwent multidisciplinary evaluation prior to surgery. Electronic medical records were retrospectively reviewed by the authors at their respective institutions to collect data.

Deidentified data was transferred in a HIPAA-compliant manner to the lead institution 50 via data transfer agreement protocols. Degree of symptoms with COVID infection was categorized as: asymptomatic, mild (outpatient management), moderate (inpatient management) and severe (ICU care). Descriptive statistical analysis was utilized.

Complete patient data is listed in Table 1 . Results from the data analysis are listed in Table 2 . Data on fifty-three patients was collected from nine bariatric programs in the United States. 81.1% of patients were women. The average age was 42.9 (range for ileus, one episode of esophageal spasm, and one incisional hematoma requiring evacuation. There were no deaths within the study period.

This case series of 53 patients who recovered from COVID-19 and underwent 75 bariatric surgery revealed no 30-day mortalities. Morbidity related to cardiovascular, pulmonary, or VTE complications was also not observed. In general, complication rates of 4% and mortality rates of 0.1% have been found for patients undergoing metabolic and bariatric surgery in the United States [9] There was variability in terms of preoperative workup for patients after initial 80 COVID-19 diagnosis. The most consistently reported criteria was complete resolution of symptoms (98.1% of patients) before surgery. It stands to reason that patients should be screened immediately before surgery for the most common symptoms of COVID-19 which include fever, cough, dyspnea and myalgias / fatigue [1] . Persistent loss of taste and smell occurred in a small number of patients who were otherwise considered 85 symptom free at the time of surgery in this study.

Repeating COVID-19 testing with the goal of a negative molecular test result before surgery occurred 77.4% of the time but was not considered standard of care in all institutions. If surgeons chose to employ this approach tests should be performed as close to the day of surgery as possible while factoring in turn-around time of testing [10] . Post-COVID recovery chest imaging took place in 24.5% of patients before surgery. This suggests routine chest radiography after recovery from COVID and prior to bariatric surgery may not be necessary in all cases. The benefit would be that if a characteristic pulmonary abnormality is detected it may be pertinent to postpone surgery and pursue further workup including pulmonary function testing [11] . 100

Preoperative pulmonology consultation was routinely done in only 9.4% of patients in this study and revealed no abnormalities.

reported in recent literature. These complications have been associated with increased morbidity and mortality in the acute illness phase and for weeks afterwards [12] [13] . In 105 this series, post-discharge extended VTE prophylaxis was administered in 22.6% of patients. In most cases VTE prophylaxis was extended beyond the time of hospitalization for an underlying risk factor or disease process but not because of the history of COVID-19 diagnosis specifically [14] . No VTE related events occurred in this series of patients. 110

Obesity is the most significant risk factor for mortality in patients under 45 years old who contract COVID-19 [15] . Given evidence that bariatric surgery may be protective, there is no indication that surgery should be delayed [16] . This study shows that in patients with obesity who have survived COVID19, bariatric surgery is still safe. It is in agreement with a recently published case series including 35 European patients 115 J o u r n a l P r e -p r o o f who underwent bariatric surgery after recovery from COVID-19 [17] . Bariatric surgery should not be considered elective in the setting of this pandemic as patients with obesity are at increased risk of mortality and it can be conducted safely both before and after infection.

Limitations on this study include recall bias as the participating surgeons 120 generated included patients from various methods including memory and EMR review.

Small sample size makes it difficult to draw accurate conclusions on ongoing needs for the best approach to pre-op workup in these patients as well as need for extended VTE prophylaxis after surgery. Most patients in this study fell into the asymptomatic or mildly symptomatic categories with initial COVID-19 diagnosis. Complication rates may be 125 different for patients with moderate or severe disease.

Elective bariatric surgery after recovery from COVID-19 in this cohort of patients was not associated with increases in morbidity or mortality rates compared to national averages.

J o u r n a l P r e -p r o o f -Bariatric surgery is safe in patients who have recovered from COVID-19 -No additional pulmonary workup or post discharge VTE prophylaxis appears to be necessary as it relates to previous COVID-19 diagnosis alone.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

New ICD-10-CM Code for the 2019 Novel Coronavirus (COVID-19)

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Order of the Commissioner of Public Health

COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection:, An international cohort study

American Society for Metabolic and Bariatric Surgery

COVID-19 Testing : Key Issues

Imaging profile of the COVID-19 infection: radiologic findings and literature review

Coagulopathy in COVID-19

Thrombosis in COVID-19

Who Should Get Extended Thromboprophylaxis After Bariatric Surgery?: A Risk Assessment Tool to Guide Indications for

COVID-19), by Age Group and State, United States

Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity

Bariatric surgery in patients with previous COVID-19 infection. Surgery for Obesity and Related Diseases